Reference : A three-year double-blind placebo-controlled study of risedronate in postmenopausal o...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/140201
A three-year double-blind placebo-controlled study of risedronate in postmenopausal osteoporosis
English
Taquet, AN [> >]
Clemmensen, B [> >]
Zegels, Brigitte [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Ravin, P [> >]
Christiansen, C [> >]
Roumagnac, I [> >]
Reginster, Jean-Yves mailto [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
1996
Osteoporosis International
Springer Science & Business Media B.V.
6
S1
262
Yes (verified by ORBi)
International
0937-941X
1433-2965
Godalming
United Kingdom
World Congress on Osteoporosis
Du 18 mai 1996 au 23 mai 1996
European Foundation for Osteoporosis and Bone Diseases (EFFO) in cooperation with the National Osteoporosis Foundation (NOF)
USA
http://hdl.handle.net/2268/140201
also: http://hdl.handle.net/2268/140210

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
A three-year double-blind placebo-controlled study of risedronate in postmenopausal osteoporosis.pdfPublisher postprint132.76 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.